Cargando…

Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion

BACKGROUND: Fiducial markers are the superior method to compensate for interfractional motion in liver SBRT. However this method is invasive and thereby limits its application range. In this retrospective study, the compensation method for the interfractional motion using fiducial markers (gold stan...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinz, Christian, Gerum, Sabine, Freislederer, Philipp, Ganswindt, Ute, Roeder, Falk, Corradini, Stefanie, Belka, Claus, Niyazi, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924279/
https://www.ncbi.nlm.nih.gov/pubmed/27350636
http://dx.doi.org/10.1186/s13014-016-0662-2
_version_ 1782439841560002560
author Heinz, Christian
Gerum, Sabine
Freislederer, Philipp
Ganswindt, Ute
Roeder, Falk
Corradini, Stefanie
Belka, Claus
Niyazi, Maximilian
author_facet Heinz, Christian
Gerum, Sabine
Freislederer, Philipp
Ganswindt, Ute
Roeder, Falk
Corradini, Stefanie
Belka, Claus
Niyazi, Maximilian
author_sort Heinz, Christian
collection PubMed
description BACKGROUND: Fiducial markers are the superior method to compensate for interfractional motion in liver SBRT. However this method is invasive and thereby limits its application range. In this retrospective study, the compensation method for the interfractional motion using fiducial markers (gold standard) was compared to a new non-invasive approach, which does rely on the organ motion of the liver and the relative tumor position within this volume. METHODS: We analyzed six patients (3 m, 3f) treated with SBRT in 2014. After fiducial marker implantation, all patients received a treatment CT (free breathing, without abdominal compression) and a 4D-CT (consisting of 10 respiratory phases). For all patients the gross tumor volumes (GTVs), internal target volume (ITV), planning target volume (PTV), internal marker target volumes (IMTVs) and the internal liver target volume (ILTV) were delineated based on the CT and 4D-CT images. CBCT imaging was used for the standard treatment setup based on the fiducial markers. According to the patient coordinates the 3 translational compensation values (t(x), t(y), t(z)) for the interfractional motion were calculated by matching the blurred fiducial markers with the corresponding IMTV structures. 4 observers were requested to recalculate the translational compensation values for each CBCT (31) based on the ILTV structures. The differences of the translational compensation values between the IMTV and ILTV approach were analyzed. RESULTS: The magnitude of the mean absolute 3D registration error with regard to the gold standard overall patients and observers was 0.50 cm ± 0.28 cm. Individual registration errors up to 1.3 cm were observed. There was no significant overall linear correlation between the respiratory motion and the registration error of the ILTV approach. CONCLUSIONS: Two different methods to calculate the translational compensation values for interfractional motion in stereotactic liver therapy were evaluated. The registration accuracy of the ILTV approach is mainly limited by the non-rigid behavior of the liver and the individual registration experience of the observer. The ILTV approach lacks the accuracy that would be desired for stereotactic radiotherapy of the liver.
format Online
Article
Text
id pubmed-4924279
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49242792016-06-29 Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion Heinz, Christian Gerum, Sabine Freislederer, Philipp Ganswindt, Ute Roeder, Falk Corradini, Stefanie Belka, Claus Niyazi, Maximilian Radiat Oncol Research BACKGROUND: Fiducial markers are the superior method to compensate for interfractional motion in liver SBRT. However this method is invasive and thereby limits its application range. In this retrospective study, the compensation method for the interfractional motion using fiducial markers (gold standard) was compared to a new non-invasive approach, which does rely on the organ motion of the liver and the relative tumor position within this volume. METHODS: We analyzed six patients (3 m, 3f) treated with SBRT in 2014. After fiducial marker implantation, all patients received a treatment CT (free breathing, without abdominal compression) and a 4D-CT (consisting of 10 respiratory phases). For all patients the gross tumor volumes (GTVs), internal target volume (ITV), planning target volume (PTV), internal marker target volumes (IMTVs) and the internal liver target volume (ILTV) were delineated based on the CT and 4D-CT images. CBCT imaging was used for the standard treatment setup based on the fiducial markers. According to the patient coordinates the 3 translational compensation values (t(x), t(y), t(z)) for the interfractional motion were calculated by matching the blurred fiducial markers with the corresponding IMTV structures. 4 observers were requested to recalculate the translational compensation values for each CBCT (31) based on the ILTV structures. The differences of the translational compensation values between the IMTV and ILTV approach were analyzed. RESULTS: The magnitude of the mean absolute 3D registration error with regard to the gold standard overall patients and observers was 0.50 cm ± 0.28 cm. Individual registration errors up to 1.3 cm were observed. There was no significant overall linear correlation between the respiratory motion and the registration error of the ILTV approach. CONCLUSIONS: Two different methods to calculate the translational compensation values for interfractional motion in stereotactic liver therapy were evaluated. The registration accuracy of the ILTV approach is mainly limited by the non-rigid behavior of the liver and the individual registration experience of the observer. The ILTV approach lacks the accuracy that would be desired for stereotactic radiotherapy of the liver. BioMed Central 2016-06-27 /pmc/articles/PMC4924279/ /pubmed/27350636 http://dx.doi.org/10.1186/s13014-016-0662-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Heinz, Christian
Gerum, Sabine
Freislederer, Philipp
Ganswindt, Ute
Roeder, Falk
Corradini, Stefanie
Belka, Claus
Niyazi, Maximilian
Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion
title Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion
title_full Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion
title_fullStr Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion
title_full_unstemmed Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion
title_short Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion
title_sort feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924279/
https://www.ncbi.nlm.nih.gov/pubmed/27350636
http://dx.doi.org/10.1186/s13014-016-0662-2
work_keys_str_mv AT heinzchristian feasibilitystudyonimageguidedpatientpositioningforstereotacticbodyradiationtherapyoflivermalignanciesguidedbylivermotion
AT gerumsabine feasibilitystudyonimageguidedpatientpositioningforstereotacticbodyradiationtherapyoflivermalignanciesguidedbylivermotion
AT freisledererphilipp feasibilitystudyonimageguidedpatientpositioningforstereotacticbodyradiationtherapyoflivermalignanciesguidedbylivermotion
AT ganswindtute feasibilitystudyonimageguidedpatientpositioningforstereotacticbodyradiationtherapyoflivermalignanciesguidedbylivermotion
AT roederfalk feasibilitystudyonimageguidedpatientpositioningforstereotacticbodyradiationtherapyoflivermalignanciesguidedbylivermotion
AT corradinistefanie feasibilitystudyonimageguidedpatientpositioningforstereotacticbodyradiationtherapyoflivermalignanciesguidedbylivermotion
AT belkaclaus feasibilitystudyonimageguidedpatientpositioningforstereotacticbodyradiationtherapyoflivermalignanciesguidedbylivermotion
AT niyazimaximilian feasibilitystudyonimageguidedpatientpositioningforstereotacticbodyradiationtherapyoflivermalignanciesguidedbylivermotion